Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ILMN

Illumina Inc

Dec 08 • 04:00PM ET

112.94

Dollar change -4.19
Percentage change -3.58	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-7.12	Insider Own	0.43%	Shs Outstand	158.80M	Perf Week	2.87%
Market Cap	17.93B	Forward P/E	108.47	EPS next Y	1.04	Insider Trans	-0.27%	Shs Float	158.13M	Perf Month	2.02%
Income	-1125.00M	PEG	-	EPS next Q	-0.05	Inst Own	89.22%	Short Float / Ratio	3.43% / 2.21	Perf Quarter	-27.02%
Sales	4.46B	P/S	4.02	EPS this Y	-67.39%	Inst Trans	2.94%	Short Interest	5.42M	Perf Half Y	-43.68%
Book/sh	37.33	P/B	3.03	EPS next Y	50.61%	ROA	-10.52%	Target Price	131.50	Perf Year	-45.84%
Cash/sh	5.88	P/C	19.22	EPS next 5Y	21.26%	ROE	-17.82%	52W Range	89.00 - 238.55	Perf YTD	-44.14%
Dividend	-	P/FCF	106.12	EPS past 5Y	-	ROI	-13.91%	52W High	-52.66%	Beta	1.09
Dividend %	-	Quick Ratio	1.28	Sales past 5Y	11.97%	Gross Margin	61.43%	52W Low	26.90%	ATR	5.16
Employees	11500	Current Ratio	1.69	Sales Q/Q	0.36%	Oper. Margin	-2.08%	RSI (14)	55.16	Volatility	4.58% 5.03%
Optionable	Yes	Debt/Eq	0.39	EPS Q/Q	80.37%	Profit Margin	-25.20%	Rel Volume	0.95	Prev Close	117.13
Shortable	Yes	LT Debt/Eq	0.37	Earnings	Nov 09 AMC	Payout	-	Avg Volume	2.45M	Price	112.94
Recom	2.55	SMA20	10.90%	SMA50	-1.92%	SMA200	-35.14%	Volume	2,324,609	Change	-3.58%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250
Aug-25-22	Initiated	Credit Suisse	Neutral	$230
Jul-13-22	Downgrade	Barclays	Equal Weight → Underweight	$350 → $150
Jan-18-22	Upgrade	Stifel	Hold → Buy	$480
Jan-11-22	Upgrade	Barclays	Underweight → Equal Weight
Jan-07-22	Upgrade	BofA Securities	Underperform → Neutral
Jan-06-22	Resumed	Piper Sandler	Overweight	$450
Jan-06-22	Resumed	Morgan Stanley	Equal-Weight	$425
Oct-15-21	Resumed	Cowen	Outperform	$550
Aug-19-21	Downgrade	SVB Leerink	Outperform → Mkt Perform	$425
Jun-01-21	Upgrade	Evercore ISI	Underperform → In-line	$400
Mar-31-21	Upgrade	Canaccord Genuity	Hold → Buy	$445

Show Previous Ratings

Dec-04-23 02:40PM	Investors Sue Illumina (ILMN) for Concealing Facts Concerning GRAIL Acquisition Hagens Berman (GlobeNewswire)
Nov-30-23 09:57AM	ILMN Shareholders Upcoming Deadline: Bronstein, Gewirtz & Grossman LLC Reminds Investors of The Illumina, Inc. to Contact the Firm (Business Wire)
09:45AM	Video: Merging Discovery With Clinical Care at Ontario Institute for Cancer Research (ACCESSWIRE)
Nov-29-23 04:29PM	Factbox-US Supreme Court case on SEC could have wide impact on agency enforcement (Reuters) +5.21%
Nov-28-23 06:46PM	Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses (GlobeNewswire)
05:56AM	Loading…
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-20-23 03:07PM	ILMN Stock News: Shareholders with Significant Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against Illumina, Inc. (Business Wire)
Nov-17-23 07:22AM	Weaker Guidance Dragged Illumina (ILMN) in Q3 (Insider Monkey)
Nov-16-23 04:50PM	Illumina: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:15AM	Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors (GlobeNewswire)
06:49AM	Illumina (ILMN) Launches Initiative on Pathogen Sequencing (Zacks)
Nov-15-23 05:57PM	Investors Sue Illumina (ILMN) for Concealing Facts Concerning GRAIL Acquisition (GlobeNewswire)
Nov-14-23 04:05PM	Illumina To Webcast Upcoming Investor Conferences (PR Newswire) +5.07%
Nov-13-23 03:53PM	Worried About Deficit Stan Druckenmiller Is Still Very Bullish On These Stocks (Insider Monkey) -5.67%
09:15AM	Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries (PR Newswire)
11:55AM	Loading…
Nov-11-23 11:55AM	Illumina, Inc. (NASDAQ:ILMN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 06:12PM	Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses (GlobeNewswire) -8.05%
05:12PM	S&P 500 Gains and Losses Today: Hologic Announces Strong Results, Stock Buyback (Investopedia)
04:04PM	DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance Again (Investor's Business Daily)
03:33PM	Illumina Shares Hit a 10-Year Low as the Company's Customers Pull Back on Spending (Investopedia)
01:36PM	Stocks to Watch Friday: Illumina, Trade Desk, Meta (The Wall Street Journal)
12:01PM	Midday Movers: Hologic and Meta Platforms Gain, Illumina Sinks (Investopedia)
09:46AM	Illumina Stock Is the Worst Performer in the S&P 500. Grail Isnt the Only Issue. (Barrons.com)
09:32AM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:01AM	Illumina Stock Tumbles. Grail Isnt the Only Issue. (Barrons.com)
08:01AM	Q3 2023 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
07:57AM	Midday movers: Wynn Resorts, Plug Power, Walt Disney and more (Investing.com)
07:52AM	Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut (Zacks)
05:04AM	Illumina shares slip after genetic testing group lowers profit guidance (Investing.com)
Nov-09-23 06:30PM	Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:49PM	Loading…
05:49PM	Illumina cuts annual profit forecast for second straight quarter (Reuters)
04:17PM	Illumina: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023 (PR Newswire)
05:54AM	Q3 2023 Somalogic Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 09:50AM	Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role (GlobeNewswire)
Nov-07-23 04:00PM	Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally (Business Wire)
09:45AM	The Race Results Are in - And So Is the Marine Genomic Data (ACCESSWIRE)
Nov-06-23 10:41AM	Seeking Clues to Illumina (ILMN) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:36AM	Several Reasons Hampered Illumina (ILMN) in Q3 (Insider Monkey)
Nov-02-23 10:00AM	Earnings Preview: Illumina (ILMN) Q3 Earnings Expected to Decline (Zacks) +5.25%
09:30AM	Aegis Writes a New Chapter on Pathogen Surveillance (ACCESSWIRE)
Nov-01-23 09:15AM	Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors (PR Newswire)
06:44AM	Here's Why Illumina (ILMN) Declined in Q3 (Insider Monkey)
Oct-31-23 06:55PM	Illumina: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Oct-30-23 04:05PM	11 Best Long-Term Stocks To Buy For High Returns (Insider Monkey)
03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
05:25AM	11 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
Oct-26-23 11:40AM	LGND vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
07:15AM	7 F-Rated Stocks to Sell Before November (InvestorPlace)
Oct-23-23 12:45PM	The Future of Sustainable Mining Belongs to the Microbe (ACCESSWIRE)
Oct-20-23 10:31AM	Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research (PR Newswire)
08:32AM	Is the Options Market Predicting a Spike in Illumina (ILMN) Stock? (Zacks)
Oct-19-23 09:30AM	Illumina Included on 2023 List of 100 Best Corporate Citizens List (ACCESSWIRE)
Oct-18-23 09:45AM	What the Diagnostic Odyssey Looks Like - And How We Can End It (ACCESSWIRE) -5.63%
Oct-17-23 10:26PM	Carl Icahn Criticizes Short Sellers at Investor Conference (Bloomberg)
09:24PM	UPDATE 2-Carl Icahn sues Illumina board for violating 'fiduciary duties' (Reuters)
07:37PM	Carl Icahn sues Illumina board for violating 'fiduciary duties' (Reuters)
07:36PM	Activist Icahn sues Illumina board over Grail acquisition - FT (Reuters)
Oct-13-23 02:33PM	UPDATE 2-Illumina to divest Grail within a year if it does not win challenge in EU court (Reuters)
02:26PM	Illumina to divest Grail within a year if it does not win challenge in EU court (Reuters)
02:22PM	Illumina to divest cancer test maker Grail if it does not win challenge in EU court (Reuters)
02:10PM	Illumina responds to European Commission's divestiture order (PR Newswire)
Oct-12-23 04:26PM	Illumina Ordered by EU to Unwind Grail Acquisition (The Wall Street Journal) -5.45%
11:52AM	ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories (Benzinga)
09:36AM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:30AM	How Do Genetic Factors Play a Role in Chronic Pain and Opioid Use Disorder? (ACCESSWIRE)
06:36AM	EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail (AP Finance)
05:56AM	Illumina ordered by EU antitrust regulators to sell Grail (Reuters)
Oct-11-23 04:22PM	UPDATE 2-Illumina to divest cancer test maker Grail if it loses US or EU court appeal (Reuters)
04:18PM	Illumina to divest cancer test maker Grail if it loses US or EU court appeal (Reuters)
04:12PM	Illumina to divest Grail if it loses final court appeals (Reuters)
04:05PM	Illumina Posted a Stewardship-Focused Presentation for Investors (PR Newswire)
Oct-10-23 05:26PM	Illumina to get EU order on Thursday to divest Grail, source says (Reuters)
11:45AM	Q&A: An Illumina Interns Shift From Academia to Industry (ACCESSWIRE)
11:40AM	LGND vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
12:02AM	Israel imposes complete siege on Gaza (Financial Times)
Oct-09-23 07:50PM	PRESS DIGEST- Financial Times - Oct. 10 (Reuters)
08:37AM	UPDATE 2-EU regulatory order for Illumina to sell Grail could come next week - FT (Reuters)
08:29AM	NVIDIA and Illumina have been highlighted as Zacks Bull and Bear of the Day (Zacks)
08:15AM	EU regulators to order Illumina to sell Grail - FT (Reuters)
08:05AM	EU regulators to order Illumina to sell $8bn cancer treatment group (Financial Times)
06:44AM	EU regulators to order Illumina to sell Grail - Financial Times (Investing.com)
06:20AM	Bear of the Day: Illumina (ILMN) (Zacks)
02:03AM	14 Best Cancer Stocks To Buy Now (Insider Monkey)
Oct-06-23 01:29PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Oct-05-23 04:05PM	Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (PR Newswire)
Oct-04-23 07:31PM	Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
10:08AM	Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors (GlobeNewswire)
Sep-29-23 02:45PM	Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors (GlobeNewswire)
12:31PM	Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
08:23AM	Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
02:54AM	14 Best Depressed Stocks To Buy Now (Insider Monkey)
Sep-28-23 04:21PM	15 Recent Activist Investor Campaigns (Insider Monkey)
Sep-27-23 12:30PM	Summiting Italys Stelvio Pass for Cancer Research (ACCESSWIRE)
Sep-26-23 05:08PM	2 of Carl Icahn's Holdings Approach 52-Week Lows (GuruFocus.com)
Sep-20-23 12:12PM	13 Best Beaten Down Stocks To Buy Now (Insider Monkey)
07:42AM	Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up (Zacks)
Sep-19-23 12:31PM	Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
09:00AM	Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials (GlobeNewswire)
Sep-18-23 09:45AM	Yes, Its Possible: Students Visit Illumina and See Their Potential Careers (ACCESSWIRE)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoyt Aimee L	SVP, Chief People Officer	Nov 07	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jul 24	Sale	190.08	500	95,040	46,022	Jul 26 06:14 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jun 22	Sale	200.00	500	100,000	46,522	Jun 26 05:23 PM
EPSTEIN ROBERT S	Director	May 25	Option Exercise	71.09	7,600	540,284	14,764	May 25 04:34 PM
Hoyt Aimee L	SVP, Chief People Officer	Mar 01	Sale	199.06	3,917	779,737	2,881	Mar 03 11:22 AM
Aravanis Alexander	SVP, Chief Technology Officer	Feb 22	Sale	201.74	5,398	1,088,982	2,922	Feb 23 06:08 PM
Reeves Kathryne Gambrell	SVP, Chief Marketing Officer	Feb 21	Option Exercise	0.00	2,789	0	6,973	Feb 23 05:51 PM
Pegels Kevin Carl	Chief of Global Operations	Feb 21	Option Exercise	0.00	1,097	0	7,539	Feb 23 05:46 PM
Hoyt Aimee L	SVP, Chief People Officer	Feb 21	Option Exercise	0.00	5,282	0	8,163	Feb 23 05:42 PM
Febbo Phillip G.	SVP Chief Medical Officer	Feb 21	Option Exercise	0.00	3,522	0	8,475	Feb 23 05:34 PM
GOSWAMI JOYDEEP	SVP Chief Financial Officer	Feb 21	Option Exercise	0.00	4,696	0	12,292	Feb 23 05:38 PM
Dadswell Charles	SVP & General Counsel	Feb 21	Option Exercise	0.00	5,282	0	11,948	Feb 23 05:29 PM
Aravanis Alexander	SVP, Chief Technology Officer	Feb 21	Option Exercise	0.00	9,292	0	12,214	Feb 23 06:08 PM
deSouza Francis A	President and CEO	Feb 21	Option Exercise	0.00	23,473	0	100,419	Feb 23 05:59 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Feb 21	Option Exercise	0.00	5,869	0	44,145	Feb 23 05:55 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Feb 06	Sale	211.57	500	105,785	38,276	Feb 08 05:29 PM
Hoyt Aimee L	SVP, Chief People Officer	Jan 09	Sale	205.57	871	179,051	2,796	Jan 11 04:27 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jan 06	Sale	204.58	500	102,290	38,662	Jan 10 04:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience